Alpine Immune Sciences Inc Stock, NASDAQ:ALPN
188 East Blaine Street, Suite 200, Seattle, Washington 98102
United States of America
Number of Employees: 57
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases; immuno-oncology; and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.